Assistant Professor Veera D. Panuganty, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, is publicly visible through medical oncology, breast cancer, tamoxifen metabolism, CYP2D6 phenotype, and oncology wellness leadership. Dr. Panuganty has presented work on clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen. Her mission is to support evidence-informed medical oncology while contributing to a healthier cancer-care culture and leadership of the department’s wellness committee.